Childhood Central Nervous System Germ Cell Tumor

Childhood Central Nervous System Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00638898	Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor	completed	Phase 1	25	City of Hope Medical CenterOTHER	1	Mar 20, 2025	clinicaltrials
NCT00326664	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Mar 7, 2016	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	terminated	Phase 1	129	National Cancer Institute (NCI)NIH	2	Nov 5, 2014	clinicaltrials
NCT00946335	ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors	completed	Phase 1	31	National Cancer Institute (NCI)

Data updated 23 days agoSource updated Mar 20, 2025source: clinicaltrials